Cell proliferation is insufficient, but loss of tuberin is necessary, for chemically induced nephrocarcinogenicity.

Although 2,3,5-tris-(glutathion-S-yl)hydroquinone (TGHQ; 2.5 micromol/kg ip) markedly increased cell proliferation within the outer stripe of the outer medulla (OSOM) of the kidney in both wild-type (Tsc2(+/+)) and mutant Eker rats (Tsc2(EK/+)), only TGHQ-treated Tsc2(EK/+) rats developed renal tumors, indicating that cell proliferation per se was not sufficient for tumor development. Tuberin expression was initially induced within the OSOM after TGHQ treatment but was lost within TGHQ-induced renal tumors. High extracellular signal-regulated kinase (ERK) activity occurred in the OSOM of Tsc2(EK/+) rats at 4 mo and in TGHQ-induced renal tumors. Cyclin D1 was also highly expressed in TGHQ-induced renal tumors. Reexpression of Tsc2 in tuberin-negative cells decreased ERK activity, consistent with the growth-suppressive effects of this tumor suppressor gene. Thus 1) stimulation of cell proliferation after toxicant insult is insufficient for tumor formation; 2) tuberin induction after acute tissue injury suggests that Tsc2 is an acute-phase response gene, limiting the proliferative response after injury; and 3) loss of Tsc2 gene function is associated with cell cycle deregulation.

[1]  H. Yoon,et al.  Transformation of kidney epithelial cells by a quinol thioether via inactivation of the tuberous sclerosis‐2 tumor suppressor gene , 2001, Molecular carcinogenesis.

[2]  T. Monks,et al.  Stress- and growth-related gene expression are independent of chemical-induced prostaglandin E(2) synthesis in renal epithelial cells. , 2000, Chemical research in toxicology.

[3]  H. Onda,et al.  Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. , 1999, The Journal of clinical investigation.

[4]  T. Monks,et al.  Quinol-glutathione conjugate-induced mutation spectra in the supF gene replicated in human AD293 cells and bacterial MBL50 cells. , 1999, Cancer research.

[5]  R. Safirstein,et al.  MAPK activation determines renal epithelial cell survival during oxidative injury. , 1999, American journal of physiology. Renal physiology.

[6]  Alan R. Saltiel,et al.  Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo , 1999, Nature Medicine.

[7]  A. DeCaprio The toxicology of hydroquinone--relevance to occupational and environmental exposure. , 1999, Critical reviews in toxicology.

[8]  T. Noda,et al.  Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice. , 1999, Cancer research.

[9]  J. Usuda,et al.  Mitogen-activated protein kinase antisense oligonucleotide inhibits the growth of human lung cancer cells. , 1999, International journal of oncology.

[10]  G. Rubin,et al.  gigas , a Drosophila Homolog of Tuberous Sclerosis Gene Product-2, Regulates the Cell Cycle , 1999, Cell.

[11]  Takashi Tsuruo,et al.  Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors , 1999, Oncogene.

[12]  R. Yeung,et al.  Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[13]  H. Kleiner,et al.  Immunochemical analysis of quinol-thioether-derived covalent protein adducts in rodent species sensitive and resistant to quinol-thioether-mediated nephrotoxicity. , 1998, Chemical Research in Toxicology.

[14]  H. Onda,et al.  Tuberous Sclerosis Gene 2 Product Modulates Transcription Mediated by Steroid Hormone Receptor Family Members* , 1998, The Journal of Biological Chemistry.

[15]  E. Mccleskey,et al.  Rap1 mediates sustained MAP kinase activation induced by nerve growth factor , 1998, Nature.

[16]  Weiya Ma,et al.  Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[17]  C. Walker Molecular Genetics of Renal Carcinogenesis , 1998, Toxicologic pathology.

[18]  T. Monks,et al.  Cytotoxicity and cell-proliferation induced by the nephrocarcinogen hydroquinone and its nephrotoxic metabolite 2,3,5-(tris-glutathion-S-yl)hydroquinone. , 1997, Carcinogenesis.

[19]  J. Declue,et al.  Role of the Tuberous Sclerosis Gene-2 Product in Cell Cycle Control , 1997, The Journal of Biological Chemistry.

[20]  N. Minato,et al.  Human SPA-1 Gene Product Selectively Expressed in Lymphoid Tissues Is a Specific GTPase-activating Protein for Rap1 and Rap2 , 1997, The Journal of Biological Chemistry.

[21]  H. Tsuda,et al.  Somatic mutation of the tuberous sclerosis (Tsc2) tumor suppressor gene in chemically induced rat renal carcinoma cell. , 1997, The Journal of urology.

[22]  M. Cobb,et al.  Mitogen-activated protein kinase pathways. , 1997, Current opinion in cell biology.

[23]  D. Wolf,et al.  Methyltert-Butyl Ether Causes α2u-Globulin Nephropathy and Enhanced Renal Cell Proliferation in Male Fischer-344 Rats , 1997 .

[24]  E. Golemis,et al.  The Tuberous Sclerosis 2 Gene Product, Tuberin, Functions as a Rab5 GTPase Activating Protein (GAP) in Modulating Endocytosis* , 1997, The Journal of Biological Chemistry.

[25]  J. Bonifacino,et al.  Co-localization of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus. , 1996, Oncogene.

[26]  J. Pouysségur,et al.  Cyclin D1 Expression Is Regulated Positively by the p42/p44MAPK and Negatively by the p38/HOGMAPK Pathway* , 1996, The Journal of Biological Chemistry.

[27]  J. Declue,et al.  Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[28]  T. Kobayashi,et al.  Suppression of the neoplastic phenotype by replacement of the Tsc2 gene in Eker rat renal carcinoma cells. , 1996, Biochemical and biophysical research communications.

[29]  S. Kuroda,et al.  Activation of Brain B-Raf Protein Kinase by Rap1B Small GTP-binding Protein (*) , 1996, The Journal of Biological Chemistry.

[30]  A. Scabar,et al.  Apparent preferential loss of heterozygosity at TSC2 over TSC1 chromosomal region in tuberous sclerosis hamartomas , 1996, Genes, chromosomes & cancer.

[31]  T. Goldsworthy,et al.  Hereditary renal cell carcinoma in the Eker rat: a unique animal model for the study of cancer susceptibility. , 1995, Toxicology Letters.

[32]  M. Kawaichi,et al.  Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. , 1995, Cancer research.

[33]  G. Xiao,et al.  Allelic loss at the tuberous sclerosis 2 locus in spontaneous tumors in the Eker rat , 1995, Molecular carcinogenesis.

[34]  Peter J. Cullen,et al.  Identification of a specific lns(l,3,4,5)P4-binding protein as a member of the GAP1 family , 1995, Nature.

[35]  T. Kobayashi,et al.  cDNA structure, alternative splicing and exon-intron organization of the predisposing tuberous sclerosis (Tsc2) gene of the Eker rat model. , 1995, Nucleic acids research.

[36]  J. Declue,et al.  Identification of Tuberin, the Tuberous Sclerosis-2 Product. TUBERIN POSSESSES SPECIFIC Rap1GAP ACTIVITY (*) , 1995, The Journal of Biological Chemistry.

[37]  K. Okazaki,et al.  MAP kinase activation is essential for oncogenic transformation of NIH3T3 cells by Mos. , 1995, Oncogene.

[38]  Y. Kubo,et al.  Early detection of Knudson's two-hits in preneoplastic renal cells of the Eker rat model by the laser microdissection procedure. , 1995, Cancer research.

[39]  A. Knudson,et al.  Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[40]  C. Walker,et al.  Increased susceptibility to in vitro transformation of cells carrying the Eker tumor susceptibility mutation. , 1994, Carcinogenesis.

[41]  Y. Kubo,et al.  Allelic loss at the predisposing gene locus in spontaneous and chemically induced renal cell carcinomas in the Eker rat. , 1994, Cancer research.

[42]  A. Brunet,et al.  Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts. , 1994, Oncogene.

[43]  A. Green,et al.  Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients , 1994, Nature Genetics.

[44]  S. Thomas,et al.  Identification and characterization of the tuberous sclerosis gene on chromosome 16 , 1993, Cell.

[45]  A. Knudson,et al.  Susceptibility to renal carcinoma in the Eker rat involves a tumor suppressor gene on chromosome 10. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[46]  J. Huff,et al.  Toxicity and carcinogenicity of hydroquinone in F344/N rats and B6C3F1 mice. , 1992, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[47]  T. Sasaki,et al.  Microinjection of smg/rap1/Krev-1 p21 into Swiss 3T3 cells induces DNA synthesis and morphological changes , 1992, Molecular and cellular biology.

[48]  T. Goldsworthy,et al.  Predisposition to renal cell carcinoma due to alteration of a cancer susceptibility gene. , 1992, Science.

[49]  M. Hirose,et al.  Induction of Renal Cell Tumors in Rats and Mice, and Enhancement of Hepatocellular Tumor Development in Mice after Long‐term Hydroquinone Treatment , 1991, Japanese journal of cancer research : Gann.

[50]  F. McCormick,et al.  Molecular cloning of a GTPase activating protein specific for the Krev-1 protein p21 rap1 , 1991, Cell.

[51]  T. Monks,et al.  Sequential oxidation and glutathione addition to 1,4-benzoquinone: correlation of toxicity with increased glutathione substitution. , 1988, Molecular pharmacology.

[52]  S. Mizusaki,et al.  Mutagenicity of polycyclic aromatic hydrocarbons and quinones on Salmonella typhimurium TA97. , 1985, Mutation research.

[53]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[54]  R. Velsen,et al.  Centrosema Mosaic: a Plant Virus Disease transmitted by both Aphids and Plant Bugs , 1961, Nature.

[55]  J. Mossige,et al.  A Dominant Gene for Renal Adenomas in the Rat , 1961, Nature.

[56]  C. Walker,et al.  Carcinogenicity of a nephrotoxic metabolite of the "nongenotoxic" carcinogen hydroquinone. , 2001, Chemical research in toxicology.

[57]  J. de Gunzburg,et al.  Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues. , 1997, The American journal of pathology.

[58]  D. Wolf,et al.  Methyl tert-butyl ether causes alpha2u-globulin nephropathy and enhanced renal cell proliferation in male Fischer-344 rats. , 1997, Toxicology and applied pharmacology.

[59]  Deisinger Pj,et al.  HUMAN EXPOSURE TO NATURALLY OCCURRING HYDROQUINONE , 1996 .

[60]  Y. Kubo,et al.  A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer , 1995, Nature Genetics.

[61]  I. Florin,et al.  Screening of tobacco smoke constituents for mutagenicity using the Ames' test. , 1980, Toxicology.